DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Jubilant Ingrevia Limited — Utilisation of Funds

NSE 2 hrs ago·7 Oct 2026, 12:17 pm

Jubilant Ingrevia

Jubilant Ingrevia Limited has informed stock exchanges about the utilisation of funds raised through a recent fundraising round. This disclosure is a standard regulatory requirement for listed companies to ensure transparency regarding the deployment of capital.

For investors, this news signals that the company is actively moving forward with its expansion plans. The utilisation of funds typically indicates progress in strategic initiatives, such as capacity expansion, research and development, or debt reduction, which are positive indicators for long-term growth.

Investors should monitor the specific use of these funds to ensure they align with the company’s stated strategic goals. Keeping an eye on how these investments impact the company’s operational efficiency and future profitability will be key to understanding the long-term value of the stock.